Eileen Brandenburger, PhD is a European Patent Attorney and Head of Intellectual Property at Recursion and Exscientia, a NASDAQ listed clinical stage AI-driven TechBio company, which is accelerating the development of patient centric medicines by encoding, automating and transforming the drug discovery and development process.
She is an experienced legal professional with a track record of building teams and providing advice to businesses and executives in the pharma, tech and life sciences industries. She has specialist expertise in technical and commercial IP including patent and trade secret strategy and contracting at the interface of life sciences and tech.